Login to Your Account



Fewer Studies in India

East Asia Emerging as Clinical Trials Hub for Pharma, Biotech

By Cornelia Zou
Contributing Writer

Wednesday, November 20, 2013

BEIJING – Asia is rapidly becoming the location of choice for clinical studies by many leading drug developers, with the number of studies in East Asia already topping 14,000, and Mainland China, Hong Kong, South Korea and Taiwan emerging as popular locations.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription